We cannot yet assess the impact that the IRA will have on us or the pharmaceutical industry as a whole, but it will likely be significant.
All entries for: Cancer
April 24, 2026
Apollomics Inc.
Neutral Outlook
Foster City, CA
51-200 employees
These initiatives culminated in the enactment of the IRA in August 2022, which allows HHS to negotiate the selling price of certain drugs and biologics that CMS reimburses under Medicare Part B and Part D, although this will only apply to high-expenditure single-source drugs that have been approved for at least seven years (11 years for biologics).
Disease Area: Cancer, Rare Diseases
Drug Type: Small Molecule